April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Rapamycin Reduces Macrophages While Cyclosporine A Reduces Neutrophils In The Retina In Mouse Endotoxin-induced Uveitis
Author Affiliations & Notes
  • Steve Louie
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Maura Crowley
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Omar Delgado
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Natasha Buchanan
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Bruce Jaffee
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Sha-Mei Liao
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1360. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Steve Louie, Maura Crowley, Omar Delgado, Natasha Buchanan, Bruce Jaffee, Sha-Mei Liao; Rapamycin Reduces Macrophages While Cyclosporine A Reduces Neutrophils In The Retina In Mouse Endotoxin-induced Uveitis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1360.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the effects of 2 immunosupressant agents (rapamycin, an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1), and cyclosporine A, a calcineurin and apoptosis inhibitor) on retinal inflammation in a mouse endotoxin (lipopolysaccharide=LPS)-induced uveitis model.

Methods: : LPS (50 ug) was administered intraperitoneally to 7-week-old C57BL/6 female mice. Rapamycin or cyclosporine A was dosed via oral gavage one hour prior to LPS challenge. Eyes were collected and dissected 3, 8, 16, and 24 hours post LPS administration. Samples were analyzed for cytokines/chemokines and leukocytes. Retinal neutrophils and macrophages/monocytes of retinal flat mounts were detected by immuno-staining with Gr-1 and F4/80, respectively. Fluorescent cells were quantified using Axiovision software.

Results: : Increasing doses of rapamycin from 0.3 mg/kg to 10 mg/kg resulted in a dose-dependent reduction of macrophages but not neutrophils in the retina at 24 hours. Rapamycin at 10 mg/kg reduced retinal macrophages/monocytes by 85% (p<0.001). In contrast, cyclosporine A had no significant effect on macrophages but reduced neutrophils by 55% (p<0.01) at 30 mg/kg. Rapamycin markedly inhibited LPS-induced plasma ICAM-1 production by >75% (p<0.001). At 3-8 hours after LPS administration, rapamycin potently blocked Th1-associated cytokines such as IL-12p70, IFN-γ, and IL-2 in the eyes (70-100% reduction, p < 0.01), likely due to the reduction in macrophages. Cyclosporine A, on the other hand, augmented LPS-induced plasma IL-10 (an anti-inflammatory cytokine) level by >4-fold (p<0.01).

Conclusions: : Rapamycin specifically inhibits LPS-induced infiltration of macrophages/monocytes but not neutrophils into the mouse retina. Cyclosporine A partially inhibits LPS-induced infiltration of neutrophils. Rapamycin and cyclosporine A also exhibited different effects on cytokines and cell adhesion molecules in response to LPS. Taken together, these results suggest that the two immunosuppressant drugs have distinct effects on LPS-trigged innate immune responses.

Keywords: uveitis-clinical/animal model • cytokines/chemokines • cyclosporine 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×